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Serotonin1A receptorThe actin cytoskeleton is involved in a multitude of cellular responses besides providing structural support.
While the role of the actin cytoskeleton in cellular processes such as trafﬁcking and motility has been
extensively studied, reorganization of the actin cytoskeleton upon signaling by G-protein coupled receptors
(GPCRs) represents a relatively unexplored area. The G-protein coupled receptor superfamily is an important
protein family in mammals, involved in signal transduction across membranes. G-protein coupled receptors
act as major signaling hubs and drug targets. The serotonin1A receptor is a representative member of the G-
protein coupled receptor superfamily and plays a crucial role in the generation and modulation of various
cognitive, developmental and behavioral functions. In order to monitor the changes in the actin cytoskeleton
upon serotonin1A receptor signaling in a quantitative manner, we developed an approach based on high
magniﬁcation imaging of F-actin in cells, followed by image reconstruction. Our results suggest that the actin
cytoskeleton is reorganized in response to serotonin1A receptor signaling. In addition, we show that
reorganization of the actin cytoskeleton is strongly dependent on adenosine 3′,5′-cyclic monophosphate level,
and is mediated by the activation of protein kinase A. Our results are consistent with the possibility of a
feedback mechanism involving the actin cytoskeleton, adenosine 3′,5′-cyclic monophosphate level and the
serotonin1A receptor.n); AC, adenylyl cyclase; cAMP,
in D; DMSO, dimethyl sulph-
, G-protein coupled receptor;
sulfonamide; IBMX, 3-isobutyl-
; PDZ, PSD95/DlgA/ZO-1; PKA,
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G-protein coupled receptors (GPCRs) constitute the largest family
of cell surface receptors and are involved in the transduction of
extracellular stimulus to cellular interior [1,2]. These receptors are
activated by a wide variety of ligands (stimuli) ranging from biogenic
amines, amino acids, ions, peptides, proteins, and even photons [3].
GPCRs are prototypical members of the family of seven transmem-
brane domain proteins and include N800 members which together
constitute ~5% of the human genome [4]. GPCRs mediate multiple
physiological processes such as neurotransmission, cellular metabo-
lism, secretion, cellular differentiation, growth, inﬂammatory and
immune responses. It is therefore only natural that GPCRs have
emerged as major targets for the development of novel drug
candidates in all clinical areas and represent ~50% of current drug
targets [5,6]. Interestingly, although GPCRs represent ~50% of current
drug targets, only a small fraction of all GPCRs are presently targeted
by drugs [7]. This points out the exciting possibility that the receptorsthat are not recognized yet could be potential drug targets for diseases
that are difﬁcult to treat by currently available drugs. In the overall
context of the importance of GPCRs in cellular signaling and their
potential as drug targets, GPCR biology represents an ever expanding,
and keenly studied area of research in contemporary biology.
Cellular signaling by GPCRs involves their activation by ligands
present in the extracellular environment and the subsequent
transduction of signals to the interior of the cell through concerted
changes in their transmembrane domain structure [8]. The major
paradigm in GPCR signaling is that ligand mediated stimulation of
these receptors leads to the activation of heterotrimeric GTP-binding
proteins (G-proteins) [9]. The key steps involved in this process are
agonist-induced guanine nucleotide exchange of GDP by GTP on the
G-protein α subunit. This is followed by conformational changes in
the GPCR and dissociation or rearrangement of the Gα from Gβγ
subunits. The activated G-protein subunits subsequently elicit an
array of downstream signaling events by interacting with speciﬁc
effectors like adenylyl cyclases (AC), phospholipases or ion channels.
Speciﬁcally, activation/deactivation of ACs further results in the up/
downregulation of cyclic AMP (cAMP) level.
The serotonin1A (5-HT1A) receptor is an important neurotransmit-
ter receptor and belongs to the superfamily of the seven transmem-
brane domain GPCRs. Serotonin1A receptors represent one of the
largest, evolutionarily ancient, and highly conserved families of seven
transmembrane GPCRs and is the most extensively studied of the
serotonin receptors for a number of reasons [10]. Serotonin1A
Fig. 1. Overall actin organization in CHO-5-HT1AR cells treated with actin reorganizing
agents. Cells cultured in monolayers on coverslips were ﬁxed and F- and G-actin were
stained with Alexa Fluor 546-phalloidin (red) and Alexa Fluor 488-Dnase1 (green),
respectively. Imaging was performed with a 20×/0.75 NA objective. Panel A shows
representative image of control (untreated) cells, while panels B–D correspond to cells
treated with CD, LatA and Jas, respectively. The scale bar represents 50 μm. See
Materials and methods for other details.
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tion of various cognitive, developmental and behavioral functions.
Agonists and antagonists of the serotonin1A receptor have been shown
to possess potential therapeutic effects in anxiety- or stress-related
disorders. As a result, the serotonin1A receptor serves as an important
target in the development of therapeutic agents for neuropsychiatric
disorders such as anxiety and depression. In addition, serotonin1A
receptor mediated signaling has been implicated in various neurode-
velopmental processes such as neurite growth and neuronal survival
[11].
Upon binding serotonin, the serotonin1A receptor signals via Gαi-
mediated inhibition of AC, leading to the lowering of cAMP level and
consequent downstream signaling [12–14]. The role of serotonin1A
receptor signaling in various cellular processes such as DNA synthesis
and regulation of signaling cascades has been identiﬁed previously
[12 and references therein]. The metabolism of cellular cAMP is
primarily determined by activities of AC and family of phosphodies-
terases. Interestingly, variation in amplitude, duration, and gradient of
intracellular cAMP is generated in response to different ligands [15].
In the context of GPCR signaling, cAMP-dependent protein kinase A
(PKA) represent one of the primary components via which cAMP
signaling is relayed further downstream. PKA is one of the well
characterized protein kinases in eukaryotic cells, and serves as a
model for the structure and function of cAMP binding proteins
[15,16]. The binding of cAMP to PKA leads to the dissociation of the
holoenzyme releasing its active catalytic subunit. The active catalytic
subunit generates further downstream signaling by phosphorylation
of multiple target proteins on serine and threonine residues [16–21].
Actin is one of the most abundant cytosolic proteins in eukaryotic
cells and exists in both monomeric (globular or G-actin) and polymeric
(ﬁlamentousor F-actin) forms. The twoendsof F-actin are characterized
by distinct growth rates; polymerization is relatively slow at the minus
or ‘pointed’ end and fast at the plus or ‘barbed’ end. F-actin ismaintained
in cells in dynamic equilibriumwith soluble G-actin. The extent of actin
polymerization and depolymerization is orchestrated by a number of
actin binding proteins (ABPs) in response to a variety of stimulus [22].
This provides a mechanism such that dynamic changes in the actin
cytoskeleton, apart fromproviding structural stability to the cell, also act
as a transducer in communicating signaling transients. While evidence
of direct interaction of GPCRs with the actin cytoskeleton is lacking,
several cytoskeleton-associated proteins have been reported to act as
bridges by simultaneously interactingwith GPCRs and the cytoskeleton.
For example, calmodulin and other multi-motif proteins, such as those
belonging to the ERM (ezrin/radixin/moesin) and PDZ (PSD95/DlgA/
ZO-1) domain proteins, have been shown to interact with GPCRs [23–
25]. This class of molecules, collectively termed as GPCR-interacting
proteins (GIPs) are reported to be involved in trafﬁcking and scaffolding
of GPCRs on the plasma membrane, thereby regulating receptor
signaling [26,27]. It has been previously reported for the serotonin1A
receptor that the calcium binding protein calmodulin, which interacts
with PDZproteins, can bind to the third intracellular loopof the receptor
[28].
In addition, cAMP/PKA signaling is known to induce signiﬁcant
changes in cellular architecture, such as dissolution of stress ﬁbers and
induction of stellate morphology in neurons and other cells. For
example, increase in the intracellular cAMP level has been reported to
cause signiﬁcant changes in the cellular architecture of ﬁbroblasts and
neuronal cells [29–32]. Elevation of cAMP level has been suggested to
activate PKA that results in inhibition of RhoA, a GTPase actively
involved in actin ﬁlament dynamics andmyosin phosphorylation [31].
Nonetheless, the role of cAMP/PKA mediated reorganization on the
actin cytoskeleton has not been explored in terms of GPCR signaling.
In this context, we have previously reported that the signaling
efﬁciency of the serotonin1A receptor, as monitored by its ability to
reduce cellular cAMP level, is enhanced upon actin cytoskeleton
destabilization [33]. Importantly, our results show that the lateralmobility (i.e., mobile fraction) of serotonin1A receptors in the plasma
membrane exhibits a correlated increase with receptor signaling upon
actin cytoskeleton destabilization. Interestingly, we also observed an
increase in receptor mobility when the cAMP level was increased
independently by directly activating AC, implying a possible reorga-
nization of the actin cytoskeleton with changes in cAMP level [33]. In
this work, we have explored the effect of serotonin1A receptor
signaling on the actin cytoskeleton organization in order to address
the possibility of cytoskeletal reorganization upon GPCR signaling. To
quantitatively monitor changes in the actin cytoskeletal network, we
have employed advanced microscopy-based image reconstruction
techniques. Our results suggest that the actin cytoskeleton is
reorganized in response to serotonin1A receptor signaling. In addition,
we show that reorganization of the actin cytoskeleton is strongly
dependent on cAMP level, and is mediated by activation of PKA.2. Materials and methods
2.1. Materials
MgCl2, CaCl2, cytochalasin D (CD), latrunculin A (LatA), serotonin
(5-HT), penicillin, streptomycin and gentamicin sulfate were obtained
from Sigma (St. Louis, MO). D-MEM/F-12 [Dulbecco's modiﬁed Eagle
medium: nutrient mixture F-12 (Ham) (1:1)], fetal calf serum, and
geneticin (G 418) were from Invitrogen Life Technologies (Carlsbad,
CA). Alexa Fluor 546 conjugated phalloidin, Alexa Fluor 488
conjugated Dnase1 and jasplakinolide (Jas) were obtained from
Molecular Probes (Eugene, OR). Forskolin, IBMX and H-89 were
obtained from Calbiochem (San Diego, CA). Cyclic [3H]AMP assay kit
was purchased from Amersham Biosciences (Buckinghamshire, U.K.).
All other chemicals used were of the highest available purity. Water
was puriﬁed through a Millipore (Bedford, MA) Milli-Q system and
used throughout.
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2.2.1. Cells, cell culture and treatments
CHO-K1 cells stably expressing the serotonin1A receptor (~105 re-
ceptors/cell) (referred to as CHO-5-HT1AR) were used. Cells were
grown in D-MEM/F-12 (1:1) supplemented with 2.4 g/l of sodium
bicarbonate, 10% fetal calf serum, 60 μg/ml penicillin, 50 μg/ml
streptomycin, and 50 μg/ml gentamicin sulfate in a humidiﬁed
atmosphere with 5% CO2 at 37 °C. CHO-5-HT1AR cells weremaintained
in the above mentioned conditions with 200 μg/ml geneticin. Stock
solutions of CD, LatA, Jas, Fsk and H-89 were made in DMSO. Further
concentrations for treatments were prepared upon dilution of the
stock in buffer A (phosphate buffered saline containing 1 mM CaCl2
and 0.5 mM MgCl2). The ﬁnal concentration of DMSO was 0.5% (v/v)
in all cases except when serotonin was used. Serotonin was directly
dissolved in buffer A to make the desired concentrations. The
concentrations used were: CD (10 μM), LatA (0.2 μM), Jas (0.2 μM),Fig. 2. Normalized cAMP level in CHO-5-HT1AR cells upon treatment with agents involved in
to cAMP level estimated in control cells and represent normalizedmeans±SE of at least three
treated with agents involved in serotonin1A receptor signaling. F- and G-actin were stained w
Imaging was performed with a 20×/0.75 NA objective. Panel B shows representative image o
Fsk+5-HT, H-89 and Fsk+H-89, respectively. The scale bar represents 50 μm. See MateriaFsk (10 μM), H-89 (3 μM) and 5-HT (10 μM). Treatments were carried
out for 30 min at room temperature (~23 °C) in all cases.
2.2.2. F- and G-actin labeling of cells
CHO-5-HT1AR cells were plated at a density of 104 cells on glass
coverslips and were grown in D-MEM/F-12 medium for 24 h. The
coverslips were washed with buffer A, and cells were treated as
speciﬁed for 30 min at room temperature (~23 °C). Following treat-
ment, cells were washed with buffer A and ﬁxed with 3.5% (v/v)
formaldehyde for 10 min. Subsequent permeabilization of cells was
carried out in presence of 0.5% (v/v) Triton X-100 and 0.05% (v/v)
Tween-20 for 6 min. Cells were washed and stained with Alexa Fluor
546 conjugated phalloidin (for F-actin) and Alexa Fluor 488 conjugated
Dnase1 (for G-actin) for 1 h prior to mounting. Since Jas is known to
competitively inhibit phalloidin binding to F-actin [34], permeabilized
cells were washed multiple times with buffer A upon Jas treatment,
prior to labeling with Alexa Fluor 546 conjugated phalloidin.serotonin1A receptor signaling are shown in panel A. Data were normalized with respect
independent measurements. Panels B–G show actin organization in CHO-5-HT1AR cells
ith Alexa Fluor 546-phalloidin (red) and Alexa Fluor 488-Dnase1 (green), respectively.
f cells treated with DMSO, while panels C–G correspond to cells treated with 5-HT, Fsk,
ls and methods for other details.
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All images were acquired on an inverted Zeiss LSM 510 Meta
confocal microscope (Jena, Germany). Alexa Fluor 546 conjugated
phalloidin imaging was performed upon excitation at 543 nm and
emission was collected from 565 to 615 nm. Alexa Fluor 488
conjugated Dnase1 was excited at 488 nm and emission was collected
from 500 to 530 nm. Low magniﬁcation images were acquired with a
20×/0.75 NA objective with an open pinhole. High magniﬁcation
images were acquired with a 63×/1.4 NA oil immersion objective
under 1 airy condition for Alexa Fluor 546 conjugated phalloidin
(93 μm, giving a ﬁxed z-slice of 0.32 μm). The images shown in Figs. 3,
5 and 7 represent the projected sections from the base (attached to
the cover slip) to ~3 μm (10–12 sections) into the cell.
2.2.4. Estimation of cAMP level in cells
The ability of the agonist to downregulate the forskolin-stimulated
increase in cAMP level in cells was assessed as described previously
[33]. Brieﬂy, CHO-5-HT1AR cells were plated at a density of 104 cells
per well in 24-well plates and grown in D-MEM/F-12 medium for
24 h. All treatments were performed for 30 min in buffer A. Cells were
rinsed with PBS and incubated with 10 μM Fsk at 23 °C for 30 min in
serum-free medium. The phosphodiesterase inhibitor IBMX (50 μM)
was present during this treatment. After incubation, cells were lysed
in 10 mM Tris and 5 mM EDTA, pH 7.4 buffer. Cell lysates were boiled
for 15–20 min and spun for 15 min in a refrigerated Eppendorf 5417R
centrifuge at ~25,000 g to remove precipitated proteins. The amount
of cAMP in an aliquot of the supernatant was estimated using the [3H]
cAMP assay, based on the protein binding method described
previously [35]. Relative cAMP level was calculated upon normaliza-
tion of the data to the cAMP content in control cells.
2.2.5. Image and data analysis
Iso-surface (i.e., a contour made upon joining voxels of equal
ﬂuorescence intensity) generation of selected sections was performed
using Bitplane software (Bitplane AG, Zurich, Switzerland; see http://Fig. 3. Organization of the actin cytoskeleton in CHO-5-HT1AR cells treated with actin
reorganizing agents. The actin cytoskeleton was stained with Alexa Fluor 546-
phalloidin and a projection of 10–12 sections from the base (~3 μm from the coverslip
into the cell) is shown. Panel A shows a projected image for cells treated with DMSO,
while panels B–D correspond to cells treated with CD, LatA and Jas, respectively. All
treatments were carried out in buffer A for 30 min. The scale bar represents 20 μm. See
Materials and methods for other details.www.bitplane.com/go/products/imaris for details). Iso-surfaces were
generated upon thresholding of images followedby applying aGaussian
ﬁlter. The estimated volumes enclosed by iso-surfaces were normalized
to the projected area of the cells for the given ﬁeld. The projected area
was determined manually by utilizing the software provided with LSM
510 Meta Confocal microscope (Zeiss, Jena, Germany). Further plotting
and analysis of the estimated parameters were carried out using Origin
software version 7.0 (OriginLab Corp., Northampton,MA) andMicrosoft
Excel 2007 (Redmond, WA). Signiﬁcance levels were estimated by
Student's two-tailed unpaired t-test using Graphpad Prism software
version 4.0 (San Diego, CA).
3. Results
3.1. Quantitative estimate of F-actin organization
In order to quantitatively estimate the extent of actin reorganiza-
tion, CHO-5-HT1AR cells were treated with actin-reorganizing agentsFig. 4. Iso-surface generation and quantitation of F-actin. Iso-surfaces of the same
selection of sections as shown in Fig. 3 were generated using the Iso-surface tool in
Imaris. The volume formed by the generated iso-surface was normalized to the
projected area of cells in the ﬁeld using the software provided with LSM 510 Meta
confocal microscope. Panel A shows the iso-surface image of cells treated with DMSO,
while panels B–D correspond to cells treated with CD, LatA and Jas, respectively. Panel E
shows the quantitative measure of F-actin. Data represent means±S.E. of at least three
independent and matched measurements performed on different days with N8 cells in
the ﬁeld (* corresponds to a p-valueb0.05, compared to DMSO treated cells). See
Materials and methods for other details.
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Dnase1. Phalloidin and Dnase1 were utilized to simultaneously label
F- andG-actin [36,37].We employed actin-reorganizing agents, namely,
LatA, CD and Jas, to induce reorganization of the cellular actin
cytoskeleton. While LatA and CD are known to induce F-actin
depolymerization, Jas is known to induce F-actin formation [34,38,39].
As shown in Fig. 1, treatment of cells with LatA and CD resulted in
fragmentation of ﬁlamentous actin (Fig. 1B and C). Treatment with Jas,
on the other hand, led to an increase in the F-actin content (Fig. 1D). To
explore possible reorganization of the actin cytoskeleton in response to
serotonin1A receptor signaling, we monitored actin reorganization
induced by agents involved in such signaling. As mentioned above,
ligand-mediated activation of the serotonin1A receptor leads to a
reduction of cellular cAMP level [12]. Since the basal level of cAMP are
often low to monitor further reduction, Fsk (a direct activator of AC) is
commonly employed to increase cAMP level prior to ligand stimulation.
We used H-89 to monitor the effect of blocking downstream signaling
mediated via the cAMP/PKA pathway on the actin cytoskeleton. H-89 is
known to bind to the catalytic subunit of PKA in a competitive fashion
against ATP and inhibits kinase activity [40]. The estimated cAMP levels
in cells treated with agents involved in serotonin1A receptor signaling
are shown in Fig. 2A, and the corresponding actin organization is shown
in Fig. 2B–G. While no discernable change was observed in the case of
cells treated with DMSO, serotonin or H-89 (Fig. 2B, C and F
respectively),we observed a reduction of F-actin content in cells treated
with Fsk (Fig. 2D) in agreement with depolymerization of F-actin in the
presence of high cAMP level (shown in Fig. 2A). Thedepolymerization of
F-actin was reversed either in cells treated with serotonin and Fsk, or in
cells treated with Fsk and H-89 (Fig. 2E and G). These observations
indicate that while serotonin1A receptor signaling reduces cAMP level
(Fig. 2A), the destabilization of F-actin at high cAMP level is brought
about by an activated PKA dependent pathway (see later text).
Interestingly, the cAMP level was found to be higher in the case of
cells treatedwith Fsk andH-89, compared to cells treatedwith Fsk alone
(Fig. 2A). This could possibly be due to the competitive nature of H-89Fig. 5. Projected images of cellular F-actin upon increase in cellular cAMP. The actin
cytoskeleton was stained with Alexa Fluor 546-phalloidin and a projection of 10–12
sections from the base (~3 μm from the coverslip into the cell) is shown. Panel A shows
a projected image for cells treated with DMSO, while panels B–D correspond to cells
treated with Fsk, H-89 and Fsk+H-89, respectively. All treatments were carried out in
buffer A for 30 min. The scale bar represents 20 μm. See Materials and methods for
other details.binding to PKA, resulting in an increase in the content of free cAMP
available in cells.
In order to monitor these changes in the actin cytoskeleton in a
quantitative fashion, we estimated the ratio of F-actin to the content of
G-actin (F/G ratio). The integrated ﬂuorescence intensities originating
from a group of cells in the two emission channels of the microscope
(the red and green channels, corresponding to F- and G-actin) were
utilized to determine the F/G ratio. Unfortunately, while these
measurements were statistically robust due to the collection from a
large number of cells in the ﬁeld, the F/G ratio exhibited low dynamic
range and high variance (percent deviation ~50; data not shown),
possibly due to intrinsic variation in the cellular population. To
circumvent the above problems, we performed high magniﬁcation
imaging of F-actin followed by image reconstruction. Images were
acquired at 63× magniﬁcation and 10–12 sections (z-slice of 0.32 μm)
were selected from the base (~3 μmfrom the surface of the cell attached
to the coverslip) and an iso-surface of F-actin (primarily representing
the ventral stress ﬁbers [41]) was generated. The projected images of
cells treated with actin reorganizing agents are shown in Fig. 3, and theFig. 6. Loss of F-actin upon increase of cellular cAMP. Iso-surfaces of the same selection
of sections as shown in Fig. 5 were generated using the Iso-surface tool in Imaris (as
described in Fig. 4). Panel A shows the iso-surface image of cells treated with DMSO,
while panels B–D correspond to cells treated with Fsk, H-89 and Fsk+H-89,
respectively. The quantitative measure of F-actin is shown in panel E. Data represent
means±S.E. of at least three independent and matched measurements performed on
different days with N8 cells in the ﬁeld (* corresponds to a p-valueb0.05, compared to
DMSO treated cells). See Materials and methods for other details.
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that the total volume enclosed by the iso-surface, normalized to the
projected area of the cells, provides best estimate of changes in F-actin
content. The estimate of F-actin derived this way (averaged over ~25
cells) is shown in Fig. 4E. As canbeseen in Fig. 4E, treatments leading to a
loss of F-actin (CD and LatA) displayed a signiﬁcant reduction in the
estimated parameter,whereas treatmentwith Jas exhibited an increase.
In contrast to estimates of actin reorganization using lowmagniﬁcation
imaging, estimation of F-actin using high magniﬁcation imaging by this
approach improved the dynamic range and overall reproducibility.
3.2. Increase in cAMP level leads to a reduction of F-actin
To monitor changes in F-actin when cAMP level is elevated, we
quantitated F-actin in cells treatedwith Fsk. Asmentioned earlier, Fsk is
a direct activator of AC and leads to an increase in cellular cAMP level.
Figs. 5 and 6 show that elevation of cAMP level by Fsk leads to a
reduction of F-actin. To further probe the mechanism of actin
depolymerization mediated by increased level of cAMP (induced by
Fsk), we used H-89, an inhibitor of PKA. Interestingly, inhibiting PKA by
H-89 rescues F-actin depolymerization to a large extent. These
observations imply that elevated cAMP level results in actin depoly-
merization,mediated by activation of PKA. Importantly, H-89 treatment
alone led to an increase in F-actin content, probably by inhibiting basal
PKA mediated signaling in these cells. Interestingly, the reduction in F-
actin brought about by elevated cAMP level appears to reorganize the
cytoskeleton differently than observed for actin depolymerizing agents
like CD and LatA. While CD and LatA tend to fragment F-actin into foci,
high level of cAMP results in an overall reduction in F-actin without the
generation of foci (see Figs. 3B, C and 5B, and Figs. 4B, C and 6B).
3.3. Reorganization of the actin cytoskeleton upon serotonin1A receptor
activation
To monitor whether activation of the serotonin1A receptor and
subsequent signaling bring about changes in the actin cytoskeleton,
we estimated F-actin upon treatment of cells with serotonin (Figs. 7Fig. 7. Projected images of cellular F-actin in CHO-5-HT1AR cells treated with agents involved
546-phalloidin and a projection of 10–12 sections from the base (~3 μm from the coverslip
while panels B–E correspond to cells treated with DMSO, 5-HT, Fsk, and Fsk+5-HT, respec
20 μm. See Materials and methods for other details.and 8). Stimulation of cells with serotonin led to an increase in F-actin
compared to control (untreated) cells (Fig. 8F). Interestingly, we
observed that treatment of cells with DMSO led to an increase in F-
actin. Importantly, the reduction of F-actin brought about by
stimulation of cells with Fsk (Fig. 7D) was recovered when cells
were treated with Fsk in the presence of serotonin (Fig. 7E). The
increase in F-actin content upon serotonin treatment suggests that
serotonin1A receptor signaling is involved in reduction of basal cAMP
level, driving cellular actin polymerization. However, the assay
utilized by us to estimate cAMP level was unable to differentiate
any change in cAMP level between control and serotonin treated cells
(Fig. 2A). This could possibly be due to the inherent insensitivity of the
assay at low cAMP concentrations. Taken together, our results imply
that signaling by the serotonin1A receptor mediated through cAMP/
PKA could dynamically modulate the actin cytoskeleton by lowering
cAMP level.4. Discussion
The actin cytoskeleton is involved in a multitude of cellular
responses in addition to providing structural support. While the role
of the actin cytoskeleton in cellular processes such as trafﬁcking and
motility has been intensely studied [42], the reorganization of the
actin cytoskeleton upon GPCR signaling has been rarely addressed. In
this work, we present a quantitative estimate of actin reorganization
upon activation of the serotonin1A receptor. Our results suggest that
elevated cAMP level leads to a reduction in F-actin content through
activation of PKA. In addition, we report that serotonin1A receptor
signaling results in an increase in F-actin content in cells, possibly due
to the reduction of basal cAMP level (Fig. 8). Tomonitor the changes in
the actin cytoskeleton in a quantitative fashion, we have developed an
approach based on high magniﬁcation imaging of F-actin in cells,
followed by image reconstruction. With the beneﬁt of an improved
dynamic range and low variance of the acquired data, we were able to
ascribe reorganization of the actin cytoskeleton upon alteration of
cAMP level (which is mediated by serotonin1A receptor signaling).in serotonin1A receptor signaling. The actin cytoskeleton was stained with Alexa Fluor
into the cell) is shown. Panel A shows a projected image for control (untreated) cells,
tively. All treatments were carried out in buffer A for 30 min. The scale bar represents
Fig. 8. F-actin destabilization is inhibited in the presence of serotonin. Iso-surfaces of the same selection of sections as shown in Fig. 7 were generated using the Iso-surface tool in
Imaris (as described in Fig. 4). Panel A shows a projected image for control (untreated) cells, while panels B–E correspond to cells treated with DMSO, 5-HT, Fsk, and Fsk+5-HT,
respectively. The quantitative measure of F-actin is shown in panel F. Data represent means±S.E. of at least three independent and matched measurements performed on different
days with N8 cells in the ﬁeld (* corresponds to a p-valueb0.05, compared to control cells). See Materials and methods for other details.
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oligomerization of serotonin1A receptors in the plasma membrane is
regulated by the integrity of the underlying actin cytoskeleton [33,43–
45]. We previously observed a progressive increase in the fraction of
mobile receptors, estimated from FRAP measurements with increasing
actin depolymerization [33]. Signiﬁcantly, the signaling efﬁciency of the
receptor (deﬁned as the extent of reduction of cAMP in Fsk stimulated
cells for a given ligand concentration) exhibited a remarkable
correlation to the increase inmobile fractionunder theseconditions [33].
These results, in combination with our present data, generate the
following interesting aspects of serotonin1A receptor signaling: (i)
serotonin1A receptor signaling leads to an increase in F-actin content by
reducing cAMP level; (ii) increase in cAMP level leads to F-actin
destabilization; and (iii) destabilization of F-actin results in an increase
in receptor mobility (mobile fraction of receptors) with a correlated
increase in receptor signaling. In the continuous presence of extracel-
lular ligand, the serotonin1A receptor, cAMP level and the actin
cytoskeleton network could be involved in a negative feedback cyclecapable of generating oscillatory response [46]. These responses could
be further modulated in vivo, depending upon the presence of
extracellular ligand gradients, as well as differential structural organi-
zation of the underlying cytoskeleton in specialized cells such as
neurons. Interestingly, differential mobility of proteins between
navigating and non-navigating growth cones in neurons, possibly due
to the differences in the sub-membraneous actin cytoskeleton, has been
previously observed [47]. In addition, with growing evidence in favor of
localized signaling by cAMP [48], our results raise an interesting
possibility of a dynamic system involving the actin cytoskeleton, cAMP
level and the serotonin1A receptor.Wenote that theabove system, in the
presence of extracellular serotonin, could be driven by a local negative
feedback loop. According to this model, a localized increase in cAMP
level can reorganize the actin cytoskeleton, leading to increased
receptor mobility and therefore signaling by the serotonin1A receptor,
which in effect would reduce cAMP level (see Fig. 9). Interestingly,
ligand gradient or cAMP dependent growth of neurons have been
reported earlier [49,50].
Fig. 9. A schematic representation depicting the changes brought about in the actin
cytoskeleton by cellular cAMP level. Dynamics of the actin cytoskeleton (F-actin) is not
only sensitive to cAMP level, but also requires active PKA. In this context, if the
modulation in receptor mobility and signaling upon cytoskeletal destabilization [33]
are taken into account, the receptor, cellular cAMP and the actin cytoskeleton appear to
form a negative feedback loop. Such a feedback loop would, in principle, be capable of
generating local oscillatory response. See text for further discussion.
1928 S. Ganguly et al. / Biochimica et Biophysica Acta 1808 (2011) 1921–1929In summary, we report here quantitative measurements on the
changes in F-actin upon signaling by the serotonin1A receptor. We
observe that alterations in cAMP level regulate the organization of F-
actin. It has been recently reported that activation of the luteinizing
hormone receptor leads to a transient depolymerization of actin [51].
Interestingly, the luteinizing hormone receptor is coupled to Gαs and
leads to an increase in cAMP level. These results suggest that cellular
level of cAMP signiﬁcantly inﬂuences the balance between polymer-
ized andmonomeric forms of actin. The dynamic reorganization of the
actin cytoskeleton may represent an important determinant in GPCR
signaling.Acknowledgements
This work was supported by the Council of Scientiﬁc and Industrial
Research, Government of India. S.G. and R.S. thank Council of Scientiﬁc
and Industrial Research for the award of Senior Research Fellowships.
A.C. is anAdjunct Professor at the Special Centre forMolecularMedicine
of JawaharlalNehruUniversity (NewDelhi, India) and Indian Institute of
Science Education andResearch (Mohali, India), andHonorary Professor
at the Jawaharlal Nehru Centre for Advanced Scientiﬁc Research
(Bangalore, India). A.C. gratefully acknowledges J.C. Bose Fellowship
(Dept. of Science and Technology, Govt. of India). We thank Nandini
Rangaraj for useful discussions, and members of our laboratory for
critically reading the manuscript.References
[1] K.L. Pierce, R.T. Premont, R.J. Lefkowitz, Seven-transmembrane receptors, Nat.
Rev. Mol. Cell Biol. 3 (2002) 639–650.
[2] D.M. Rosenbaum, S.G.F. Rasmussen, B.K. Kobilka, The structure and function of
G-protein-coupled receptors, Nature 459 (2009) 356–363.
[3] M.J. Marinissen, J.S. Gutkind, G-protein-coupled receptors and signaling net-
works: emerging paradigms, Trends Pharmacol. Sci. 22 (2001) 368–376.
[4] Y. Zhang, M.E. DeVries, J. Skolnick, Structure modeling of all identiﬁed G protein-
coupled receptors in the human genome, PLoS Comput. Biol. 2 (2006) e13.
[5] M.C. Lagerström, H.B. Schiöth, Structural diversity of G protein-coupled receptors
and signiﬁcance for drug discovery, Nat. Rev. Drug Discov. 7 (2008) 339–357.
[6] R. Heilker, M. Wolff, C.S. Tautermann, M. Bieler, G-protein-coupled receptor-
focused drug discovery using a target class platform approach, Drug Discov. Today
14 (2009) 231–240.
[7] S.H. Lin, O. Civelli, Orphan G protein-coupled receptors: targets for new
therapeutic interventions, Ann. Med. 36 (2004) 204–214.
[8] U. Gether, Uncovering molecular mechanisms involved in activation of G protein-
coupled receptors, Endocr. Rev. 21 (2000) 90–113.
[9] W.M. Oldham, H.E. Hamm, Structural basis of function in heterotrimeric G
proteins, Q. Rev. Biophys. 39 (2006) 117–166.
[10] T.J. Pucadyil, S. Kalipatnapu, A. Chattopadhyay, The serotonin1A receptor: a
representative member of the serotonin receptor family, Cell. Mol. Neurobiol. 25
(2005) 553–580.
[11] A.D. Fricker, C. Rios, L.A. Devi, I. Gomes, Serotonin receptor activation leads to
neurite outgrowth and neuronal survival, Brain Res. Mol. Brain Res. 138 (2005)
228–235.
[12] J.R. Raymond, Y.V. Mukhin, T.W. Gettys, M.N. Garnovskaya, The recombinant 5-HT1A
receptor: G protein coupling and signalling pathways, Br. J. Pharmacol. 127 (1999)
1751–1764.
[13] G.J. Della Rocca, Y.V. Mukhin, M.N. Garnovskaya, Y. Daaka, G.J. Clark, L.M. Luttrell,
R.J. Lefkowitz, J.R. Raymond, Serotonin 5-HT1A receptor-mediated Erk activation
requires calcium/calmodulin-dependent receptor endocytosis, J. Biol. Chem. 274
(1999) 4749–4753.
[14] S.-C. Hsiung, A. Tin, H. Tamir, T.F. Franke, K.-P. Liu, Inhibition of 5-HT1A receptor-
dependent cell survival by cAMP/protein kinase A: role of protein phosphatase 2A
and Bax, J. Neurosci. Res. 86 (2008) 2326–2338.
[15] S. Seino, T. Shibasaki, PKA-dependent and PKA-independent pathways for cAMP-
regulated exocytosis, Physiol. Rev. 85 (2005) 1303–1342.
[16] S.S. Taylor, C. Kim, D. Vigil, N.M. Haste, J. Yang, J. Wu, G.S. Anand, Dynamics of
signaling by PKA, Biochim. Biophys. Acta 1754 (2005) 25–37.
[17] M.C. Martin, L.A. Allan, M. Lickrish, C. Sampson, N. Morrice, P.R. Clarke, Protein
kinase A regulates caspase-9 activation by Apaf-1 downstream of cytochrome c,
J. Biol. Chem. 280 (2005) 15449–15455.
[18] A.J. Shaywitz, M.E. Greenberg, CREB: a stimulus-induced transcription factor
activated by a diverse array of extracellular signals, Annu. Rev. Biochem. 68
(1999) 821–861.
[19] P.J. Stork, J.M. Schmitt, Crosstalk between cAMP and MAP kinase signaling in the
regulation of cell proliferation, Trends Cell Biol. 12 (2002) 258–266.
[20] N. Takahashi, T. Tetsuka, H. Uranishi, T. Okamoto, Inhibition of the NF-κB
transcriptional activity by protein kinase A, Eur. J. Biochem. 269 (2002) 4559–4565.
[21] H. Usui, R. Inoue, O. Tanabe, Y. Nishito, M. Shimizu, H. Hayashi, H. Kagamiyama, M.
Takeda, Activation of protein phosphatase 2A by cAMP-dependent protein kinase-
catalyzed phosphorylation of the 74-kDa B" (δ) regulatory subunit in vitro and
identiﬁcation of the phosphorylation sites, FEBS Lett. 430 (1998) 312–316.
[22] C.G. dos Remedios, D. Chhabra, M. Kekic, I.V. Dedova, M. Tsubakihara, D.A. Berry,
N.J. Nosworthy, Actin binding proteins: regulation of cytoskeletal microﬁlaments,
Physiol. Rev. 83 (2003) 433–473.
[23] S.L. Ritter, R.A. Hall, Fine-tuning of GPCR activity by receptor-interacting proteins,
Nat. Rev. Mol. Cell Biol. 10 (2009) 819–830.
[24] E. Jacoby, R. Bouhelal, M. Gerspacher, K. Seuwen, The 7 TM G-protein-coupled
receptor target family, ChemMedChem 1 (2006) 760–782.
[25] J. Bockaert, P. Marin, A. Dumuis, L. Fagni, The ‘magic tail’ of G protein-coupled
receptors: an anchorage for functional protein networks, FEBS Lett. 546 (2003) 65–72.
[26] N. Tilakaratne, P.M. Sexton, G-protein-coupled receptor-protein interactions:
basis for new concepts on receptor structure and function, Clin. Exp. Pharmacol.
Physiol. 32 (2005) 979–987.
[27] J. Bockaert, G. Roussignol, C. Bécamel, S. Gavarini, L. Joubert, A. Dumuis, L. Fagni, P.
Marin, GPCR-interacting proteins (GIPs): nature and functions, Biochem. Soc.
Trans. 32 (2004) 851–855.
[28] J.H. Turner, A.K. Gelasco, J.R. Raymond, Calmodulin interacts with the third
intracellular loop of the serotonin 5-hydroxytryptamine1A receptor at two distinct
sites: putative role in receptor phosphorylation by protein kinase C, J. Biol. Chem.
279 (2004) 17027–17037.
[29] N.J.C. Lamb, A. Fernandez, M.A. Conti, R. Adelstein, D.B. Glass, W.J. Welch, J.R.
Feramisco, Regulation of actinmicroﬁlament integrity in living nonmuscle cells by
the cAMP-dependent protein kinase and the myosin light chain kinase, J. Cell Biol.
106 (1988) 1955–1971.
[30] J.-M. Dong, T. Leung, E. Manser, L. Lim, cAMP-induced morphological changes are
counteracted by the activated RhoA small GTPase and the Rho kinase ROKα, J. Biol.
Chem. 273 (1998) 22554–22562.
[31] A.K. Howe, Regulation of actin-based cell migration by cAMP/PKA, Biochim.
Biophys. Acta 1692 (2004) 159–174.
[32] K. Szászi, K. Kurashima, K. Kaibuchi, S. Grinstein, J. Orlowski, Role of the
cytoskeleton in mediating cAMP-dependent protein kinase inhibition of the
epithelial Na+/H+ exchanger NHE3, J. Biol. Chem. 276 (2001) 40761–40768.
1929S. Ganguly et al. / Biochimica et Biophysica Acta 1808 (2011) 1921–1929[33] S. Ganguly, T.J. Pucadyil, A. Chattopadhyay, Actin cytoskeleton-dependent
dynamics of the human serotonin1A receptor correlates with receptor signaling,
Biophys. J. 95 (2008) 451–463.
[34] M.R. Bubb, A.M.J. Senderowicz, E.A. Sausville, K.L.K. Duncan, E.D. Korn,
Jasplakinolide, a cytotoxic natural product, induces actin polymerization and
competitively inhibits the binding of phalloidin to F-actin, J. Biol. Chem. 269
(1994) 14869–14871.
[35] C. Nordstedt, B.B. Fredholm, A modiﬁcation of a protein-binding method for rapid
quantiﬁcation of cAMP in cell-culture supernatants and body ﬂuid, Anal. Biochem.
189 (1990) 231–234.
[36] G.C. Knowles, C.A.G. McCulloch, Simultaneous localization and quantiﬁcation of
relative G and F actin content: optimization of ﬂuorescence labeling methods,
J. Histochem. Cytochem. 40 (1992) 1605–1612.
[37] R.P. Haugland, W. You, V.B. Paragas, K.S. Wells, D.A. DuBose, Simultaneous
visualization of G- and F-actin in endothelial cells, J. Histochem. Cytochem. 42
(1994) 345–350.
[38] P. Sampath, T.D. Pollard, Effects of cytochalasin, phalloidin, and pH on the
elongation of actin ﬁlaments, Biochemistry 30 (1991) 1973–1980.
[39] I. Spector, N.R. Shochet, Y. Kashman, A. Groweiss, Latrunculins: novel marine toxins
that disruptmicroﬁlament organization in cultured cells, Science214 (1983)493–495.
[40] T. Chijiwa, A. Mishima, M. Hagiwara, M. Sano, K. Hayashi, T. Inoue, K. Naito, T.
Toshioka, H. Hidaka, Inhibition of forskolin-induced neurite outgrowth and
protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-
dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline-
sulfonamide (H-89), of PC12D pheochromocytoma cells, J. Biol. Chem. 265 (1990)
5267–5272.
[41] S. Pellegrin, H. Mellor, Actin stress ﬁbres, J. Cell Sci. 120 (2007) 3491–3499.[42] P.A. Janmey, The cytoskeleton and cell signaling: component localization and
mechanical coupling, Physiol. Rev. 78 (1998) 763–781.
[43] S. Ganguly, P. Singh, R. Manoharlal, R. Prasad, A. Chattopadhyay, Differential
dynamics of membrane proteins in yeast, Biochem. Biophys. Res. Commun. 387
(2009) 661–665.
[44] S. Ganguly, A. Chattopadhyay, Cholesterol depletion mimics the effect of
cytoskeletal destabilization on membrane dynamics of the serotonin1A receptor:
a zFCS study, Biophys. J. 99 (2010) 1397–1407.
[45] S. Ganguly, A.H.A. Clayton, A. Chattopadhyay, Organization of higher-order
oligomers of the serotonin1A receptor explored utilizing homo-FRET in live cells,
Biophys. J. 100 (2011) 361–368.
[46] R. Thomas, R. D'Ari, Biological Feedback, CRC Press, Boca Raton, Florida, 1990.
[47] R.P. Kulkarni, M. Bak-Maier, S.E. Fraser, Differences in protein mobility between
pioneer versus follower growth cones, Proc. Natl Acad. Sci. U. S. A. 104 (2007)
1207–1212.
[48] M. Zaccolo, G.D. Benedetto, V. Lissandron, L. Mancuso, A. Terrin, I. Zamparo,
Restricted diffusion of a freely diffusible secondmessenger:mechanisms underlying
compartmentalized cAMP signaling, Biochem. Soc. Trans. 34 (2006) 495–497.
[49] H.J. Song, G.L. Ming, M.M. Poo, cAMP-induced switching in turning direction of
nerve growth cones, Nature 388 (1997) 275–279.
[50] G.L. Ming, H.J. Song, B. Berninger, C.E. Holt, M. Tessier-Lavigne, M.M. Poo, cAMP-
dependent growth cone guidance by netrin-1, Neuron 19 (1997) 1225–1235.
[51] A.B. Karlsson, E.T. Maizels, M.P. Flynn, J.C. Jones, E.A. Shelden, J.R. Bamburg, M.
Hunzicker-Dunn, Luteinizing hormone receptor-stimulated progesterone pro-
duction by preovulatory granulosa cells requires protein kinase A-dependent
activation/dephosphorylation of the actin dynamizing protein coﬁlin, Mol.
Endocrinol. 24 (2010) 1765–1781.
